Impact of urate-lowering therapy on quality of life indicators in patients with gout

Impact of urate-lowering therapy on quality of life indicators in patients with gout

Gout can have a significant impact on the quality of life (QoL) of patients.Objective: to assess the dynamics of QoL indicators and the possibility of achieving the target level of uric acid (UA) in patients with gout on febuxostat therapy, with ineffectiveness and / or contraindications to the allo...

Full description

Bibliographic Details
Main Authors:	M. N. Chikina, O. V. Zhelyabina, M. S. Eliseev
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2021-06-01
Series:	Современная ревматология
Subjects:	подагра качество жизни уратснижающая терапия фебуксостат
Online Access:	https://mrj.ima-press.net/mrj/article/view/1150

Similar Items

Rational use of recommendations for urate-lowering therapy: clinical examples
by: M. S. Eliseev, et al.
Published: (2022-06-01)

Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01)

ACR management guidelines for the treatment of gout: What’s new and what’s controversial
by: M. S. Eliseev
Published: (2021-05-01)

Colchicine for acute arthritis attacks prevention in patients with gout during urate-lowering therapy (results of a pilot study)
by: M. S. Eliseev, et al.
Published: (2021-08-01)

Urate-lowering therapy for heart failure
by: O. V. Zhelyabina, et al.
Published: (2019-09-01)

Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01)

Association of the Q141K polymorphism of the ABCG2 gene with the effectiveness of urate-lowering therapy in patients with gout (a pilot study)
by: M. S. Eliseev, et al.
Published: (2021-12-01)

Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
by: M. S. Eliseev, et al.
Published: (2022-12-01)

Experience with febuxostat in a patient with severe disabling gout
by: M. S. Eliseev, et al.
Published: (2017-09-01)

The use of febuxostat in comorbid patients with gout in real clinical practice: own data
by: E. V. Zonova, et al.
Published: (2022-06-01)

The place of febuxostat in the treatment of gout
by: A. M. Novikova, et al.
Published: (2020-09-01)

Comparison of the efficacy and safety of various anti-inflammatory drugs in urate-lowering therapy initiation in patients with gout (preliminary data)
by: M. N. Chikina, et al.
Published: (2021-04-01)

ЕФЕКТИВНІСТЬ УРАТОЗНИЖУВАЛЬНОЇ ТЕРАПІЇ ІЗ ЗАСТОСУВАННЯМ АЛОПУРИНОЛУ ТА ФЕБУКСОСТАТУ У ХВОРИХ НА ПОДАГРУ
by: I. V. Orlova, et al.
Published: (2018-10-01)

The Experience of Using a Combination of Febuxostat and Canakinumab in Tophaceous Gout Complicated by Chronic Kidney Disease in a Teenage Patient: A Case Study
by: Maria I. Kaleda, et al.
Published: (2018-12-01)

Adherence to urate-lowering therapy while following the national guidelines for the management of patients with gout (preliminary evidence)
by: M. N. Chikina, et al.
Published: (2020-11-01)

Chronic kidney disease: the role of hyperuricemia and the possibility of urate-lowering therapy
by: M. S. Eliseev
Published: (2018-04-01)

Practical application of national clinical guidelines for the management of gout (preliminary data)
by: M. N. Chikina, et al.
Published: (2020-05-01)

Pharmacotherapy of gout – modern approaches and prospects
by: P. A. Lebedev, et al.
Published: (2021-08-01)

Dynamics of quality of life indicators at a multiple sclerosis
by: V. N. Karnaukh, et al.
Published: (2010-08-01)

Risk factors for type 2 diabetes mellitus in patients with gout: results from a prospective study
by: O. V. Zhelyabina, et al.
Published: (2022-02-01)

Effect of antihypertensive therapy on the life quality of patients with hypertensive encephalopathy
by: O. V. Gavrilyuk, et al.
Published: (2011-04-01)

ANALYSIS OF THE QUALITY OF LIFE OF PATIENTS WITH INOPERABLE LUNG CANCER DURING RADIOTHERAPY AND PHOTODYNAMIC THERAPY
by: Yu. A. Ragulin, et al.
Published: (2020-01-01)

Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part I: the current state of the problem
by: M. S. Eliseev, et al.
Published: (2022-10-01)

The current treatment strategy for gouty arthritis
by: M. S. Petrova, et al.
Published: (2018-09-01)

Quality of life features in patients on the second-line antituberculosis therapy
by: T. V. Pyanzova, et al.
Published: (2012-08-01)

Качество жизни и антибактериальная терапия
Published: (2018-06-01)

EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: G. F. Andreeva, et al.
Published: (2016-01-01)

Quality of life in spondyloarthritis patients receiving biological therapy
by: A. I. Akulova, et al.
Published: (2019-10-01)

Surgical dental rehabilitation of patients in remission of oncological diseases: assessment of treatment outcomes and quality of life
by: E. A. Bazikyan, et al.
Published: (2023-01-01)

Combined therapy of arterial hypertension, chronic heart failure and depressive disorders bу АСЕ inhibitor and diuretics
by: T. A. Dronova, et al.
Published: (2008-12-01)

СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ И УРАТСНИЖАЮЩАЯ ТЕРАПИЯ: КЛИНИЧЕСКИЕ АСПЕКТЫ
by: Антон Владимирович Барсуков, et al.
Published: (2022-10-01)

Quality of life of patients with locally advanced breast cancer after neutron therapy
by: V. V. Velikaya, et al.
Published: (2020-04-01)

Clinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol is used
by: M. S. Eliseev, et al.
Published: (2015-06-01)

Health-related quality of life in patients with chronic hepatitis C during combined antiviral therapy
by: V. L. Rozina, et al.
Published: (2019-12-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Evaluation of quality of life with diabetes type 1
by: A. P. Franceva, et al.
Published: (2014-04-01)

Influence of betahistine dihydrochloride and antihypertensive medication combination on neurological status and quality of life in patients with stable arterial hypertension and vertigo
by: G. F. Andreeva, et al.
Published: (2006-08-01)

Use of meloxicam (Amelotex®) in patients with chronic gout to prevent
by: M S Eliseyev, et al.
Published: (2011-12-01)

The quality of management of patients with gout in real clinical practice
by: O. V. Teplyakova, et al.
Published: (2019-03-01)

Use of etoricoxib in patients with gout in real clinical practice
by: M S Eliseyev, et al.
Published: (2013-06-01)